A next-generation tissue microarray (ngTMA) protocol for biomarker studies

Journal of Visualized Experiments

Volumn , Issue 91, 2014, Pages

  Zlobec, Inti ^a   Suter, Guido ^a   Perren, Aurel ^a   Lugli, Alessandro ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Biomarkers; Digital pathology; Issue 91; Medicine; Predictive; Prognostic; Slide scanning; Tissue microarray

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

CHEMISTRY; COLORECTAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; PROCEDURES; TISSUE MICROARRAY;

BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908346904     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51893     Document Type: Article

References (24)

1. Kononen, J. et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 4, 844-847 (1998).
2. Tzankov, A., Went, P., Zimpfer, A., & Dirnhofer, S. Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies. Exp Gerontol. 40, 737-744, doi:S0531-5565(05)00148-8 [pii] 10.1016/j.exger.2005.06.011 (2005).
3. Barlund, M. et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst. 92, 1252-1259 (2000).
4. Bubendorf, L. et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res. 59, 803-806 (1999).
5. Garcia-Caballero, T. et al. Dual-colour CISH is a reliable alternative to FISH for assessment of topoisomerase 2-alpha amplification in breast carcinomas. Breast Cancer Res Treat. 143, 81-89, doi:10.1007/s10549-013-2791-8 (2014).
6. Schraml, P. et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res. 5, 1966-1975 (1999).
7. Zlobec, I. et al. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer. Gut. 57, 1413-1419, doi:10.1136/gut.2007.141192 gut.2007.141192 [pii] (2008).
8. Hsu, F. D. et al. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol. 15, 1374-1380, doi:10.1097/01.MP.0000039571.02827.CE (2002).
9. Marin, C. et al. Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver Reproducibility. Arch Pathol Lab Med. 138, 71-75, doi:10.5858/arpa.2013-0031-OA (2014).
10. Polley, M. Y. et al. An International Ki67 Reproducibility Study. J Natl Cancer Inst 105, 1897-1906, doi:djt306 [pii] 10.1093/jnci/djt306 (2013).
11. Zlobec, I., Terracciano, L., Jass, J. R., & Lugli, A. Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Virchows Arch. 451, 763-769, doi:10.1007/s00428-007-0466-8 (2007).
12. Zlobec, I., Koelzer, V. H., Dawson, H., Perren, A., & Lugli, A. Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types. J Transl Med. 11, 104, doi:1479-5876-11-104 [pii] 10.1186/1479-5876-11-104 (2013).
13. Yoshida, A. et al. Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers. Mod Pathol. 27, 711-720, doi:10.1038/modpathol.2013.192 modpathol2013192 [pii] (2014).
14. Droeser, R. et al. Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers. BMC Cancer. 12, 134, doi:10.1186/1471-2407-12-134 1471-2407-12-134 [pii] (2012).
15. Fleischmann, A. et al. Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases. Prostate. 71, 453-460, doi:10.1002/pros.21259 (2011).
16. Wang, T. et al. Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma. Pancreas. 42, 977-982, doi:10.1097/MPA.0b013e318287885c 00006676-201308000-00013 [pii] (2013).
17. Fleischmann, A., Rotzer, D., Seiler, R., Studer, U. E., & Thalmann, G. N. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. Eur Urol. 60, 350-357, doi:10.1016/j.eururo.2011.05.035 S0302-2838(11)00524-0 [pii] (2011).
18. Zhang, Z. Q. et al. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray. World J Gastroenterol. 19, 7795-7803, doi:10.3748/wjg.v19.i43.7795 (2013).
19. Chaux, A. et al. The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases. Hum Pathol. 44, 2690-2695, doi:10.1016/j.humpath.2013.07.012 S0046-8177(13)00299-2 [pii] (2013).
20. McKenna, S. J., Amaral, T., Akbar, S., Jordan, L., & Thompson, A. Immunohistochemical analysis of breast tissue microarray images using contextual classifiers. J Pathol Inform. 4, S13, doi:10.4103/2153-3539.109871 JPI-4-13 [pii] (2013).
21. Pages, F. et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 353, 2654-2666, doi:353/25/2654 [pii] 10.1056/NEJMoa051424 (2005).
22. Komiya, A. et al. Application of a new technique, spiral tissue microarrays constructed using needle biopsy specimens, to prostate cancer research. Int J Oncol. 44, 195-202, doi:10.3892/ijo.2013.2173 (2014).
23. Quintayo, M. A. et al. Virtual tissue microarrays: A novel and viable approach to optimising tissue micro-arrays for biomarker research applied to Ductal Carcinoma in Situ (DCIS). Histopathology. 65, 2-8 doi:10.1111/his.12336 (2014).
24. Torata, N. et al. Tissue tablet method: an efficient tissue banking procedure applicable to both molecular analysis and frozen tissue microarray. Hum Pathol. 45, 143-152, doi:10.1016/j.humpath.2013.08.013 S0046-8177(13)00370-5 [pii] (2014).